New pyridazinone derivatives with vasorelaxant and platelet antiaggregatory activities

Bioorganic and Medicinal Chemistry Letters

Volumn 20, Issue 22, 2010, Pages 6624-6627

  Costas, Tamara ^a   Besada, Pedro ^a   Piras, Alessandro ^a   Acevedo, Laura ^b   Yañez, Matilde ^b   Orallo, Francisco ^b   Laguna, Reyes ^b   Terán, Carmen ^a  

^a UNIVERSITY OF VIGO   (Spain)

^b UNIVERSITY OF SANTIAGO DE COMPOSTELA   (Spain)

Author keywords

Antiplatelet agents; Butenolides; Pyridazinones; Vasorelaxant

Indexed keywords

ANTITHROMBOCYTIC AGENT; PYRIDAZINONE DERIVATIVE; VASODILATOR AGENT;

ANTICOAGULATION; ARTICLE; DRUG DESIGN; DRUG MECHANISM; DRUG STRUCTURE; DRUG SYNTHESIS; OXIDATION; THROMBOCYTE AGGREGATION INHIBITION;

BLOOD PLATELETS; CELLS, CULTURED; HUMANS; PLATELET AGGREGATION INHIBITORS; PYRIDAZINES; VASODILATOR AGENTS;

EID: 77958053596     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bmcl.2010.09.031     Document Type: Article

References (37)

1. Y. Rival, R. Hoffmann, B. Didier, V. Rybaltchenko, J.J. Bourguignon, and C.G. Wermuth J. Med. Chem. 41 1998 311
2. J.M. Contreras, I. Parrot, W. Sippl, Y. Rival, and C.G. Wermuth J. Med. Chem. 44 2001 2707
3. F. Montesano, D. Barlocco, V. Dal Piaz, A. Leonardi, E. Poggesi, F. Fanelli, and P.G. De Benedetti Bioorg. Med. Chem. 6 1998 925
4. T.C. Ramalho, M. Rocha, E. da Cunha, and M.P. Freitas Expert Opin. Ther. Patent 19 2009 1
5. A. Coelho, E. Raviña, N. Fraiz, M. Yañez, R. Laguna, E. Cano, and E. Sotelo J. Med. Chem. 50 2007 6476
6. C. Biancanali, M.P. Giovannoni, S. Pieretti, N. Cesari, A. Graciano, C. Vergelli, A. Cilibrizzi, A. di Gianuario, M. Colucci, G. Mangano, B. Garrone, L. Polenzani, and V. dal Piaz J. Med. Chem. 52 2009 7397
7. C. Meyers, M. Yañez, A. Elmaatougi, T. Verhelst, A. Coelho, N. Fraiz, G.L.F. Lemire, X. García-Mera, R. Laguna, E. Cano, B.U.W. Maes, and E. Sotelo Bioorg. Med. Chem. Lett. 18 2008 793
8. A. Siddiqui, R. Mishra, and M. Shaharyar Eur. J. Med. Chem. 45 2010 2283
9. C. Schudt, S. Winder, B. Mueller, and D. Ukena Biochem. Pharmacol. 42 1991 153
10. W. von der Saal, J.P. Holck, W. Kampe, A. Alfred Mertens, and B. Muller-Beckmannf J. Med. Chem. 32 1989 1481
11. P. Pollesello, M. Ovaska, J. Kaivola, C. Tilgmann, K. Lundström, N. Kalkkinen, I. Ulmanen, E. Nissinen, and J. Taskinen J. Biol. Chem. 269 1994 28584
12. E.N. Amin, A.-A.M. Abdel-Alim, S.G. Abdel-Moty, A.-N.A. El-Shorbagi, and M.Sh. Abdel-Rahman Arch. Pharmacol. Res. 33 2010 25
13. J.A. Bristol, I. Sircar, W.H. Moos, D.B. Evans, and R.E. Weishaan J. Med. Chem. 27 1984 1099
14. W.H. Moos, C.C. Humblet, I. Sircar, C. Rithner, R.E. Weishaar, J.A. Bristol, and A.T. McPhail J. Med. Chem. 30 1987 1963
15. L. Betti, F. Corelli, M. Floridi, G. Giannaccini, L. Maccari, F. Manetti, G. Strappaghetti, and M. Botta J. Med. Chem. 46 2003 3555
16. L. Betti, M. Floridi, G. Giannaccini, F. Manetti, G. Strappaghetti, A. Tafi, and M. Botta Bioorg. Med. Chem. Lett. 13 2003 171
17. F. Manetti, F. Corelli, G. Strappaghetti, and M. Botta Curr. Med. Chem. 9 2002 1303
18. M. Pérez, P. Canoa, G. Gómez, C. Terán, and Y. Fall Tetrahedron Lett. 45 2004 5207
19. C. Escobar, F. Fariña, and J.M. Sañudo An. Quim. 67 1971 43
20. J.J. Bourgignon, and C.G. Wermuth J. Org. Chem. 46 1981 4889
21. B.L. Mylari, W.J. Zembrowski, T.A. Beyer, C.E. Aldinger, and T.W. Siegel J. Med. Chem. 35 1992 2155
22. K.C. Nicolau, R.J. Aversa, J. Jin, and F. Rivas J. Am. Chem. Soc. 132 2010 6855
23. L. Estévez, P. Besada, Y. Fall, M. Teijeira, and C. Terán Synthesis 2010 425
24. 3) δ (ppm): 169.8, 152.1, 135.6, 132.4, 129.9, 127.8, 126.1, 110.3, 65.2, 51.4, 26.7, 19.2.
25. M. Teijeira, P.L. Suárez, G. Gómez, C. Terán, and Y. Fall Tetrahedron Lett. 46 2005 5889
26. 3) δ (ppm): 7.73 (m, 4H), 7.46 (m, 6H), 7.29 (d, J = 5.6 Hz, 1H), 6.09 (d, J = 5.6 Hz, 1H), 4.31 (m, 1H), 3.89 (m, 1H), 2.34 (m, 1H), 1.90 (m, 1H), 1.11 (s, 9H).
27. 3) δ (ppm): 160.9, 147.0, 135.5, 134.9, 133.2, 129.8, 129.6, 127.7, 62.6, 37.5, 26.8, 19.1.
28. 3) δ (ppm): 159.7, 147.6, 136.5, 135.5, 133.7, 132.6, 130.1, 129.6, 128.6, 128.5, 127.7, 127.6, 62.6, 55.1, 30.9, 30.8, 26.9, 19.2.
29. 3OD) δ (ppm): 162.6, 149.8, 133.5, 130.3, 63.5, 40.6.
30. 3) δ (ppm): 159.8, 145.9, 138.0, 136.5, 133.2, 129.8, 128.6, 128.5, 128.4, 127.7, 127.6, 73.1, 68.4, 55.1, 35.1.
31. F. Orallo, E. Álvarez, M. Camiña, J.M. Leiro, E. Gómez, and P. Fernández Mol. Pharmacol. 61 2002 294
32. S. Vilar, E. Quezada, L. Santana, E. Uriarte, M. Yañez, N. Fraiz, C. Alcaide, E. Cano, and F. Orallo Bioorg. Med. Chem. Lett. 16 2006 257
33. G.V.R. Born Nature 194 1962 927
34. C.N. Lin, H.K. Hsieh, H.H. Ko, M.F. Hsu, H.C. Lin, Y.L. Chang, M.I. Chung, J.J. Kang, J.P. Wang, and C.M. Teng Drug Dev. Res. 53 2001 9
35. R.M. Villar, J. Gil-Longo, A.H. Daranas, M.L. Souto, J.J. Fernández, S. Peixinho, M.A. Barral, G. Santafé, J. Rodríguez, and C. Jiménez Bioorg. Med. Chem. 11 2003 2301
36. S.F. De Meyers, K. Vanhoorelbeke, K. Bross, I.I. Salles, and H. Deckmyn Br. J. Haematol. 142 2008 515
37. S. Alcaro, A. Artese, M. Botta, A.T. Zizzari, F. Orallo, F. Ortuso, S. Schenone, C. Brullo, and M. Yáñez ChemMedChem 5 2010 1242